Tag: semiconductors
-
Industry-Academic Team Studies Myelin Renewal
Researchers are studying techniques for blocking proteins that damage myelin, the protective coating on nerve cells, as occurs in multiple sclerosis and other diseases.
-
Bacteria Recruited to Produce Graphene
Labs in the U.S. and the Netherlands developed techniques to sustainably produce high-quality graphene with more capabilities, using a strain of bacteria.
-
A.I. Chip Start-Up Raises $23M in Early Funds
A start-up enterprise is developing computer chips designed to run artificial intelligence, or A.I., applications but with an architecture it says can avoid memory logjams.
-
Chip Device Performs Detailed Cancer Cell Analysis
A lab-on-a-chip device shows in tests with cancer patient blood samples to detect and analyze circulating tumor cells providing precise therapy targets.
-
Crispr Used to Create Circuit-Like Genes
A biotechnology team uses genome-editing to create synthetic genes acting like electronic circuits that can be arrayed in cells like computer components.
-
NIH Funds Natural Hearing Restoration Technology
An international group of universities and companies is designing a next-generation device to restore more natural hearing to people suffering from hearing loss.
-
Spin-Off Producing Commercial-Grade Graphene
A company based on university lab research in the U.K. says it’s producing graphene, a promising carbon-based material, in quality and scale for electronics.
-
Self-Powered Sensors Monitoring Mackinac Bridge
Thousands of small sensors are being deployed across the Mackinac Bridge in northern Michigan, one of the world’s longest bridges, to monitor its integrity.
-
FDA Drafts Brain-Computer Device Regulatory Guidance
Food and Drug Administration is releasing for comment regulatory guidance for its review of implanted medical devices that connect human brains to computer systems.
-
Brain Stimulation, Recording Device Advances
An implanted device that both records activity and stimulates precise brain regions is shown to operate in lab monkeys, advancing its potential for neurological diseases.